GLP Collaboration OSOD operates in GLP and non-GLP environments and partners with laboratories and university-based partners, presenting a channel for collaborative CRO services to pharmaceutical and ocular device clients seeking compliant preclinical and clinical support.

Comprehensive Ocular Core With expertise in comparative ophthalmology, ocular imaging, electrodiagnostics, and ocular pathology, OSOD can serve as a one-stop shop for eye-related studies, appealing to firms needing integrated preclinical and early clinical evaluation capabilities.

In-House Consulting OSOD offers end-to-end consulting from study design through clinical trials and lead compound identification, enabling cross-selling of study design, data analysis, and trial execution services to sponsors seeking streamlined, integrated support.

Modest Scale, Growth Potential Revenue is in the $10M–$25M range with a lean team (11–50 employees), indicating agility and potential to scale services through strategic partnerships or expanded project scopes without large overhead, ideal for targeted account growth.

Tech-enabled Delivery The tech stack (Drupal, modern web tools, analytics) supports scalable client portals and data management for ocular studies, presenting an opportunity to upsell digital data integration, secure reporting, and remote collaboration capabilities.